Previous Article | Next Article ![]()
Journal of Clinical Microbiology, June 2000, p. 2037-2042, Vol. 38, No. 6
Division of Bacterial and Mycotic Diseases,
Respiratory Disease Branch, National Center for Infectious Diseases,
Centers for Disease Control and Prevention, Atlanta, Georgia 30333
Received 22 December 1999/Returned for modification 11 February
2000/Accepted 8 March 2000
We evaluated three rapid identification systems
0095-1137/00/$04.00+0
Comparison of Three Commercial Rapid Identification Systems
for the Unusual Gram-Positive Cocci Dolosigranulum
pigrum, Ignavigranum ruoffiae, and
Facklamia Species
The Biomerieux
rapid ID 32 STREP (ID32), the BBL Crystal rapid gram-positive identification (Crystal), and the Remel IDS RapID STR (IDS)
systems
for their ability to identify 7 strains of Alloiococcus
otitidis, 27 strains of Dolosigranulum pigrum, 3 strains of Ignavigranum ruoffiae, and 18 strains of 4 different Facklamia species. Since none of these six
species of gram-positive cocci are included in the identification
databases for these systems, the correct identification for the strains
tested should be "unacceptable ID" for the ID32 and Crystal systems
or "no choice" for the IDS system. The ID32 system identified all
27 strains of D. pigrum, 6 of 18 Facklamia
species, and 2 of 3 cultures of I. ruoffiae as
"unacceptable ID." The Crystal system identified 10 of 27 D. pigrum, 2 of 18 Facklamia species, and 2 of 3 I. ruoffiae strains as "unacceptable ID." The IDS
system identified only 1 culture of D. pigrum as "no
choice," but it also identified 2 cultures of D. pigrum
as a "questionable microcode" and 19 cultures of D. pigrum as an "inadequate ID, E. faecalis 90%,
S. intermedius 9%." A total of 2 of the 18 cultures of
Facklamia and all 3 of the I. ruoffiae
cultures were correctly identified as "no choice." The most common
misidentifications of Facklamia species by the ID32 and IDS
systems were as various Streptococcus species and as
Gemella species. In the Crystal system, the most common
erroneous identification was Micrococcus luteus. These data
indicate the need for the commercial manufacturers of these products to
update their databases to include newly described species of
gram-positive cocci.
*
Corresponding author. Mailing address: Centers for
Disease Control and Prevention, National Center for Infectious
Diseases, Division of Bacterial and Mycotic Diseases, Respiratory
Diseases Branch, Mailstop C-02, Atlanta, GA 30333. Phone: (404)
639-1379. Fax: (404) 639-3123. E-mail: rrf2{at}cdc.gov.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|